Olarinde Jeffrey Ogunmola,1 Olatunji Yusuf Oladosu,1 Adeyemi Michael Olamoyegun2 1Cardiac Care Centre, Department of Internal Medicine, Federal Medical Center, Ido Ekiti, Ekiti State, Nigeria; 2Endocrinology, Diabetes and Metabolism Unit, Department of Internal Medicine, Ladoke-Akintola University of Technology Teaching Hospital, Ogbomoso, Oyo State, Nigeria Background: There are few studies from Nigeria and Africa regarding the contribution of obesity and hypertension to cardiovascular risk in HIV-infected patients. This study investigates the prevalence of hypertension and obesity and their association with HIV infection and antiretroviral treatment (ART). Methods: We conducted a cross-sectional cohort study in a rural tertiary health ce...
International audienceAbstract Currently, the life expectancy of people living with the human immuno...
Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on ant...
BACKGROUND:With increasing adverse cardiovascular disease (CVD) outcomes in HIV/AIDS patients, the p...
Background: Highly active antiretroviral therapy (HAART) has become more accessible to Human immunod...
Background There is increased risk of cardiovascular disease among HIV seropositive individuals. T...
There is increased risk of cardiovascular disease among HIV seropositive individuals. The prevalence...
Background. The dual burden of cardiovascular diseases and Human Immunodeficiency Virus (HIV) in sub...
Hypertension and excess body weight are major risk factors of cardiovascular morbidity and mortality...
<div><p>Hypertension and excess body weight are major risk factors of cardiovascular morbidity and m...
People living with human immunodeficiency virus (HIV) are facing an increased burden of non-communic...
peer reviewedLittle is known about the major cardiovascular risk factors in HIV-infected as compared...
Background: Non-communicable diseases (NCDs) are increasing in Kenya, where HIV/AIDS remains a leadi...
Background. Elevated blood pressure has been reported among treatment naïve HIV-infected patients. W...
Objective Metabolic disorders and cardiovascular risk factors are not routinely assessed in the care...
INTRODUCTION: Studies disagree as to whether there is a greater prevalence of hypertension among HIV...
International audienceAbstract Currently, the life expectancy of people living with the human immuno...
Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on ant...
BACKGROUND:With increasing adverse cardiovascular disease (CVD) outcomes in HIV/AIDS patients, the p...
Background: Highly active antiretroviral therapy (HAART) has become more accessible to Human immunod...
Background There is increased risk of cardiovascular disease among HIV seropositive individuals. T...
There is increased risk of cardiovascular disease among HIV seropositive individuals. The prevalence...
Background. The dual burden of cardiovascular diseases and Human Immunodeficiency Virus (HIV) in sub...
Hypertension and excess body weight are major risk factors of cardiovascular morbidity and mortality...
<div><p>Hypertension and excess body weight are major risk factors of cardiovascular morbidity and m...
People living with human immunodeficiency virus (HIV) are facing an increased burden of non-communic...
peer reviewedLittle is known about the major cardiovascular risk factors in HIV-infected as compared...
Background: Non-communicable diseases (NCDs) are increasing in Kenya, where HIV/AIDS remains a leadi...
Background. Elevated blood pressure has been reported among treatment naïve HIV-infected patients. W...
Objective Metabolic disorders and cardiovascular risk factors are not routinely assessed in the care...
INTRODUCTION: Studies disagree as to whether there is a greater prevalence of hypertension among HIV...
International audienceAbstract Currently, the life expectancy of people living with the human immuno...
Abdominal or central obesity is a common morphological alteration among HIV-infected subjects on ant...
BACKGROUND:With increasing adverse cardiovascular disease (CVD) outcomes in HIV/AIDS patients, the p...